Pioneering the chemistry of early detection.

Carolyn brings more than 30 years of experience in the magnetic resonance industry to her role as Chief Executive Officer of DatChem. She was a full Professor of Radiology at Harvard Medical School and, as a foundation and board member of the ISMRM, is well versed in radiology in the USA. She has 30 years' experience as a CEO, most recently at the Brisbane-based Translational Research Institute, where she helped other companies move successfully into the business arena. Carolyn has been the lead scientist behind the DatChem technology and co-founded DatChem in 2019. She has overseen the Siemens business relationship, the development of state-of-the-art hardware and software, and the company's IP with its New York patent attorneys at Lucas Mercante.

David is a Chartered Accountant and Chartered Secretary with over 30 years' experience across professional practice and industry, with a focus on technology. This includes company secretary and senior finance roles with an ASX-listed IT company at its locations in Australia, the United States, Singapore and Europe. He worked with regional leaders to negotiate licensing agreements in real time with customers and partners. David has also worked with start-ups on structure, taxation and governance in the commercial and not-for-profit sectors, and has extensive experience in governance, risk, sustainability and international operations, including several years working in the USA.

John is a highly experienced engineering executive based in Boston with over 30 years of expertise in systems engineering, remote sensing, defence, radar and systems architecture. He serves as Head of Information Systems for DatChem, where he has been a core contributor to product development and evaluation since 2007.

David is the Practice Principal at The Breast Centre, Newcastle's only one-stop, same-day specialist medical centre for the diagnosis and treatment of breast problems, the first of its kind in Australia. He has been integral to the development of the women's health product lines and has taken over as Clinical Director on the retirement of co-founder Dr Peter Malycha.

Budi is an engineering leader with more than 15 years of software development experience and 6 years leading teams across healthcare, cloud infrastructure and enterprise software. He has built cloud platforms, developed engineering capability and delivered complex products from concept to production in both start-up and enterprise environments. His background spans software architecture, cybersecurity and regulated Software as a Medical Device (SaMD) development, combining technical leadership with architectural judgement to modernise platforms and deliver secure, scalable software.

Andrew is an experienced IT executive who has delivered projects on a global scale for multiple companies. He spent two decades in enterprise IT and security, rolling out voice platforms across a global footprint. That led to global remits spanning IT, security, telecommunications and facilities across the Americas, Europe and Asia Pacific, supporting offices in five countries with accountability for both cloud and on-premises environments. He has led a company-wide move to a SaaS pricing model, with supplier negotiations running alongside throughout.

Graham is an MR physicist with extensive experience in the hardware and software development of cutting-edge MR systems, moving between novel MR sequence implementation on commercial scanners and the discovery of new technology and advanced applications. He established the Australian National Imaging Network in 2007, an infrastructure model now being adopted globally. As technical lead for DatChem, Graham interfaces the coders with Siemens and oversees the technology at each clinical site, working closely with the tech transfer radiographers and the cloud and IT teams to ensure quality control and reproducibility. He will oversee the initiation and uptake in the USA.

Laurie brings extensive experience in the clinical and operational management of pharmaceutical and medical-device trials, including first-in-human trials. For 22 years she held senior operational, regulatory and quality roles in dedicated clinical trial facilities within three major Australian institutions. She has overseen the DatChem breast and mental health studies across multiple institutions around the world, and leads the quality and regulatory teams for DatChem.

Tyrone is an MR scientist with comprehensive experience in neuroimaging technologies, complemented by his service in the Australian Defence Force. This combination provides valuable insight into the effects of blast overpressure and PTSD, and into practical guidelines and interventions to support resilience and timely treatment during the acute phase. Working alongside Dr Crompton, Tyrone plays a major role in translating these products into practical solutions to support the health, resilience and operational effectiveness of frontline defenders.

Julia is an experienced radiographer with 17 years' experience in Australia and North America. She provides customer support and tech transfer for radiographers at new sites in Australia, and will oversee the tech transfer with the DatChem team and Siemens Healthineers into the USA sites.

Natali is an experienced radiographer with 17 years' experience across public and private radiology practices in Australia. She provides customer support and tech transfer for radiographers at new sites, and was integral to the breast clinical trial data collection, training the radiographers at the Barcelona and Adelaide sites.

Darren is a data scientist specialising in spectroscopy data and applied text mining. He interfaces with the cloud and IT teams and the radiographers to ensure data is managed in accordance with governance, and works directly with John Irvine developing and testing the classifiers in the cloud.

Lisa supports nursing staff, researchers and patients participating in trials with her clinical expertise. She has been integral to the team for eight years, interfacing with patients, radiographers and data managers. Lisa talks with patients and relays any concerns, providing patient input into the technology and its development, and has been integral to the day-to-day ethics oversight across all programs.

Gorane is an academic radiologist who specialises in diagnostic and advanced breast imaging, including high-risk MRI trials and breast screening. She has overseen the breast trial in both Australia and Spain and been integral to the development and translation of the women's health products. Gorane led the twelve-year clinical breast radiology team as the technology was rolled out in Newcastle, Brisbane, Adelaide and Barcelona, and has been central to translating it for routine use in a busy public clinical radiology setting.

David developed community-based mental health services for veterans, and community PTSD, anxiety and substance-abuse treatment services. He has held leadership roles in Queensland Health and New South Wales Health mental health services, with responsibility for the management of troops pre- and post-deployment and for Queenslanders after floods and fires. David oversaw the PTSD and blast-overpressure clinical MR studies that are now a DatChem product line, and it was David who made the call to develop an objective test and the capacity to evaluate response to therapy for ADHD.

Rosanna has been integrally involved in the military health program and clinical trials for PTSD, blast overpressure and pain. Her unique experience with defence personnel and psychology enabled a comprehensive database during the development of the classifiers and an understanding of the neurochemical pathways affected.

Jason was integral to the development of the PTSD databases and is now involved in the ADHD product. He brings a solid understanding of the effect of ADHD on patients and the need to provide a fast, objective diagnosis with a report on how the patient is responding to treatment.

Wendy was diagnosed with triple-negative breast cancer three times in three years. She is an advocate for mental health and an example of why access to supportive care for your physical and emotional wellbeing throughout a breast cancer experience is just as important as treating the cancer. Wendy is ex-Australian Defence Force and was part of the breast trial management team for several years, making her a tremendous fit for understanding and communicating on behalf of DatChem to the cancer and defence communities.

Jessica, a proud Kamilaroi woman, is a childhood cancer researcher who has been open about her own cancer experience. She was part of the breast team at Newcastle and instrumental in ensuring Aboriginal women were included in the cohort. Jessica was named the 2019 Young Australian Achiever of the Year in the UK as part of the Australia Day Honours, and is well placed to be a consumer advocate for the technology she helped develop as a young student.

Neha has over ten years of financial experience across several industries, including SaaS, with the ability to work effectively in both strategic and operational environments. She works directly with the COO and Company Secretary, David Purdue.